Genmab — August 2015
-
Så han mindsker altså hans risiko lige inden de helt store nyheder.
-
præcis Legolas23, men indtil denne kendsgerning bundfælder sig, bliver reaktionen nok negativ. Med den økonomiske eksponering Jan har mod Genmab, er det kun sund fornuft det han gør. Uanset, hvor komfortabel jeg er mht snarlig dara-godkendelse havde jeg nok gjort det samme.
-
Jeg ser bare så meget af det her i f.eks. norske selskaber. CEO sælger aktier for at betale skat og udnytte warrants. Først reagerer markedet negativt en dag eller to. Derefter er alt glemt.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
